Xinchuan Biotechnology Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $15.8M

  • Investors
  • 2

Xinchuan Biotechnology General Information

Description

Research and developer of CAR-NK immune cell therapy and cancer treatment. the company has deployed a variety of CAR-NK product pipelines for most common types of cancers such as lung cancer, liver cancer, bowel cancer, and B lymphoma. CAR-NK cell therapy can be mass-produced in a standardized way which makes it less costly compared to CART-T cell therapy, enabling cancer patients to get more affordable treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 906, 8th Floor, Building 3, Yard 10
  • Ronghua South Road, Beijing Economic and Technological Development Zone
  • Beijing
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room 906, 8th Floor, Building 3, Yard 10
  • Ronghua South Road, Beijing Economic and Technological Development Zone
  • Beijing
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xinchuan Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 28-Mar-2022 $15.8M Completed Startup
To view Xinchuan Biotechnology’s complete valuation and funding history, request access »

Xinchuan Biotechnology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
ChosenMed VC-Backed Company Minority
Rongyu Capital Growth/Expansion Minority
To view Xinchuan Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

Xinchuan Biotechnology FAQs

  • When was Xinchuan Biotechnology founded?

    Xinchuan Biotechnology was founded in 2021.

  • Where is Xinchuan Biotechnology headquartered?

    Xinchuan Biotechnology is headquartered in Beijing, China.

  • What industry is Xinchuan Biotechnology in?

    Xinchuan Biotechnology’s primary industry is Drug Discovery.

  • Is Xinchuan Biotechnology a private or public company?

    Xinchuan Biotechnology is a Private company.

  • What is Xinchuan Biotechnology’s current revenue?

    The current revenue for Xinchuan Biotechnology is .

  • How much funding has Xinchuan Biotechnology raised over time?

    Xinchuan Biotechnology has raised $15.8M.

  • Who are Xinchuan Biotechnology’s investors?

    ChosenMed and Rongyu Capital have invested in Xinchuan Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process